DelMar Pharma

DelMar Pharma

DelMar Pharma

DelMar Pharma ($DMPI) develops #cancer therapies in new indications where patients have failed or are unlikely to respond to modern therapy. #Glioblastoma
Founded
2010
Raised
$14.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$9,000,000
Post-IPO equity - 2017
$5,600,000
Post-IPO equity - 2016
Team Size
1–10
Employees
$9,000,000 Post-IPO equity
Drug Delivery Business

DelMar closes $9m public offering